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Aflatoxin is a mycotoxin and a secondary metabolite, and the most potent known liver
carcinogen that contaminates several important crops, and represents a significant
threat to public health and the economy. Available approaches reported thus far have
been insufficient to eliminate this threat, and therefore provide the rational to explore
novel methods for preventing aflatoxin accumulation in the environment. Many terrestrial
plants and microbes that share ecological niches and encounter the aflatoxin producers
have the ability to synthesize compounds that inhibit aflatoxin synthesis. However,
reports of natural aflatoxin inhibitors from marine ecosystem components that do not
share ecological niches with the aflatoxin producers are rare. Here, we show that a
non-pathogenic marine bacterium, Vibrio gazogenes, when exposed to low non-toxic
doses of aflatoxin B1, demonstrates a shift in its metabolic output and synthesizes
a metabolite fraction that inhibits aflatoxin synthesis without affecting hyphal growth
in the model aflatoxin producer, Aspergillus parasiticus. The molecular mass of the
predominant metabolite in this fraction was also different from the known prodigiosins,
which are the known antifungal secondary metabolites synthesized by this Vibrio. Gene
expression analyses using RT-PCR demonstrate that this metabolite fraction inhibits
aflatoxin synthesis by down-regulating the expression of early-, middle-, and late-
growth stage aflatoxin genes, the aflatoxin pathway regulator, aflR and one global
regulator of secondary metabolism, laeA. Our study establishes a novel system for
generation of aflatoxin synthesis inhibitors, and emphasizes the potential of the under-
explored Vibrio’s silent genome for generating new modulators of fungal secondary
metabolism.
Keywords: aflatoxins, Vibrio gazogenes, Aspergillus parasiticus, aflatoxin response metabolites (ARMs), natural
products
INTRODUCTION
Aflatoxins are a group of secondary metabolites that are synthesized primarily by food-borne
fungi such as Aspergillus parasiticus and Aspergillus flavus. These Aspergilli contaminate a
variety of economically important crops such as corn, wheat, peanuts, tree nuts, dried fruits,
vegetables, and medicinal plants in tropical and subtropical areas worldwide (Trail et al., 1995;
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Bennett and Klich, 2003; Chanda et al., 2009; Georgianna and
Payne, 2009). Aflatoxin B1 is the most potent liver carcinogen
known and its contamination in food and feed is a significant
risk factor of liver cancer risk in humans and animals (CAST,
2003; Liu and Wu, 2010). With liver carcinomas already being
the third leading cause of cancer-related mortality worldwide,
the global increase in prevalence of hepatitis B virus (HBV)
and immunocompromised population has increased the risk
of aflatoxin-induced liver cancer (Liu and Wu, 2010). The
elimination of aflatoxin accumulation in food and feed, therefore,
is of primary importance for reducing its global burden on public
health and economy.
Common agricultural approaches used for prevention of
aflatoxin contamination in crops include use of fungicides,
biocontrol agents and fungi-resistant plants, crop rotation, choice
of a plantation time that avoids the aflatoxin-conducive climatic
conditions, and control of environmental factors during post-
harvest (Kabak et al., 2006; Wu and Khlangwiset, 2010a,b;
Cary et al., 2011). However, most of these strategies are
expensive, time-consuming and have demonstrated limited
success. To complement these conventional strategies, the use
of compounds and extracts, collected from plants and microbes
that share ecological niches with the aflatoxin producers, are
becoming increasingly popular (Holmes et al., 2008). Examples
of these natural compounds include a variety of naturally
derived volatile compounds (Greene-McDowelle et al., 1999;
Zeringue, 2000; Roze et al., 2004, 2007b, 2011). Despite the
significant efforts in discovering aflatoxin biocontrol agents,
over 55 billion people worldwide still suffer from uncontrolled
exposure to aflatoxin (Strosnider et al., 2006), resulting in an
est. 25,200 to 155,000 liver cancer cases globally (Liu and
Wu, 2010). Chronic low-level exposure to aflatoxins and other
carcinogenic mycotoxins remains a serious health threat in the
USA (Kensler et al., 1992) and it is estimated that children
in rural areas of the southern USA ingest ∼40 µg aflatoxin
each day through contaminated food; a situation contributing
to the significant rise in aflatoxin-induced liver cancer cases
(Stoloff and Friedman, 1976; Van Rensburg, 1977). NIH statistics
indicate that 16,600 new cases of aflatoxin-induced liver cancer
annually in the USA (Kensler et al., 2011). Therefore, the
aflatoxin monitoring programs and the destruction and/or
decontamination of agricultural commodities, which are adopted
to meet aflatoxin levels imposed by regulations from USA and
Europe for food and feed, remain an expensive and time-
consuming process. Hence, development of additional novel
methodologies and compounds for aflatoxin elimination is
essential.
Vibrio gazogenes is an estuarine Gram-negative bacterium
that is well-known for its ability to synthesize industrially
relevant proteins such as amylases and proteases (Ratcliffe et al.,
1982) and bactericidal and fungicidal pigments, magnesidin
A (Imamura et al., 1994), prodigiosins and cycloprodigiosins
(Allen et al., 1983). Previous studies have also shown that
random mutations in this bacterium with 1-methyl-3-nitro-l-
nitrosoguanidine expanded its metabolic output and activated
the synthesis of additional bactericidal prodigiosin-related
pigments, norprodigiosin and propyl prodigiosin (Alihosseini
et al., 2010). This prompted us to hypothesize that a portion
of the bacterium’s metabolic potential remains silent under
normal growth conditions, and can be activated by genetic
and environmental perturbations. In this study, we conducted
alterations of metabolism in V. gazogenes through exposures to
non-toxic doses of the mycotoxin, aflatoxin. While aflatoxin B1
has been reported to bind to several probiotic bacteria (Kabak
et al., 2009) and has also demonstrated the ability to alter
bioluminescence responses in Vibrio fischeri (Li et al., 2011),
there remains a lack of understanding on how interaction of
aflatoxin B1 or other mycotoxins affect fundamental bacterial
cell biology. To our surprise, aflatoxin exposure to V. gazogenes
diminished prodigiosin release into the growth medium, but
additionally resulted in the production of a new compound that
demonstrated the ability to specifically inhibit aflatoxin synthesis
in the model aflatoxin producer, A. parasiticus. Here we report
the findings of this study. We establish a novel system for
generation of aflatoxin-inhibitors and provide a new avenue in
our fundamental understanding of Vibrio cell biology.
MATERIALS AND METHODS
Ethics Statement
All experiments in this study were conducted in accordance
with the general safety and biohazard protocols approved by
the Envixronmental Health and Safety, University of South
Carolina.
Strains, Media, and Growth Conditions
Aspergillus parasiticus, SU-1 (ATCC 56775), a wild-type aflatoxin
producer. The strain was grown on 100 mm Petri dishes
containing potato dextrose agar for 2 weeks. Fresh spores
collected from these colonies were used for all the experiments
in this study that involved the use of SU-1. In these experiments
the fungus was grown in aflatoxin-inducing yeast-extract-
sucrose (YES); a rich growth medium (containing 2% w/v
yeast extract, 6% w/v sucrose, pH 5.8), by inoculation of
104 spores per mL of liquid medium and incubated in the
dark (29◦C; shaking at 150 rpm). A bacterial seawater isolate
of V. gazogenes, having a 98% similarity of its 16S rRNA
gene to ATCC 43942 (Farmer et al., 1988), was grown
in Difco Marine Broth 2216 (BD Biosciences, Sparks, MD,
USA) at 28◦C in a shaking incubator (190 rpm). The
bacterial isolate is currently being submitted to ATCC and
NCBI.
Growth Measurements of A. parasiticus
and V. gazogenes
All fungal growth quantifications were performed using dry
weight measurements. Briefly, the mycelia were filtered out of the
growth media using a miracloth (Millipore, Billerica, MA, USA)
and dried at 75◦C for 6 h and the final weight was recorded. All
Vibrio growth measurements were performed using absorbance
readings of growth media at 600 nm.
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Aflatoxin Exposure Experiments,
Extraction, and Analysis of Vibrio
Metabolites
Aflatoxin B1 was commercially obtained (Sigma). Three different
doses (0.1, 0.2, or 0.3 µg/mL) of aflatoxin B1 were added
to the Vibrio growth medium at the start of the culture. In
the control flask only the vehicle (70% Methanol) was added.
To extract the metabolites from V. gazogenes the cells were
first harvested by centrifugation and extracted with 60 mL
acetone. A portion of the filtrate was concentrated by evaporation
under N2 gas. The concentrate was loaded onto a silica gel
column (1.2 cm × 15 cm) and eluted with dichloromethane:
methanol (80:1.5). The fractions were then purified on a
silica gel column using chloroform and methanol (50:2). After
purification the fractions were concentrated by evaporation
under N2 gas and re-suspended in 1 mL methanol for spectral
analysis.
ARMs Exposure Experiments and
Aflatoxin Comparisons
Comparative semi-quantitative estimations of accumulation of
aflatoxin in growth medium was performed using thin layer
chromatography (TLC) of the growth medium as described
previously (Banerjee et al., 2014).
Total RNA Purification and Transcript
Analysis
Isolation of total RNA from fungal cells exposed to aflatoxin
response metabolites from V. gazogenes was performed using
30 h old cultures. This is a time point that corresponds to the
activation of secondary metabolism (hence the expression of
aflatoxin genes in A. parasiticus) under the growth conditions
adopted in this study (Roze et al., 2007a). Purification of
total RNA and preparation of complementary DNA was
performed as described previously (Chanda et al., 2009).
Transcript levels were quantified by performing quantitative
real-time PCR assays using SsoAdvanced universal SYBR
Green supermix (BioRad Laboratories, Hercules, CA, USA)
and gene-specific forward and reverse primers (Table 1) that
TABLE 1 | List of PCR primers used for this study.
Genes Primer sequences
(1) nor-1 F 5′-CACTTAGCCAGCACGATCAA-3′
R 5′-ATGATCATCCGACTGCCTTC-3′
(2) ver-1 F 5′-AACACTCGTGGCCAGTTCTT-3′
R 5′-ATATACTCCCGCGACACAGC-3′
(3) β-tubulin F 5′-TCTCCAAGATCCGTGAGGAG-3′
R 5′-TTCAGGTCACCGTAAGAGGG- 3′
(4) aflR F 5′-ACCTCATGCTCATACCGAGG-3′
R 5′-GAAGACAGGGTGCTTTGCTC- 3′
(5) veA F 5′-TCCAGCTATCCCAAGAATGG-3′
R 5′-TAATCCCCCGATAGAGCCTT-3′
(6) laeA F 5′-ATGGGGTGTGGAAGTGTGAT-3′
R 5′-ATCGGTAAAACCAGCCTCCT-3′
were designed using Primer3 online software1. Reactions were
performed in a CFX96 thermal cycler (Bio-Rad Laboratories,
Hercules, CA, USA). As described for previous gene expression
studies in A. parasiticus (Roze et al., 2007a; Chanda et al.,
2009), expression value of each gene was obtained from
the threshold cycle values were normalized against β-tubulin
(the house keeping gene) in each sample. All RT-PCRs were
performed in triplicates for each gene per sample. Data
analyses were performed using CFX Manager software (Bio-Rad
Laboratories).
Statistical Analyses
All statistical tests were performed using GraphPad Prism
Software (GraphPad, La Jolla, CA, USA). Statistical analyses
to determine for statistical significance of differences between
control versus experimental groups were determined using one-
way ANOVA (with sample size 3). An unpaired t-test was used to
determine the gene expression effects of ARMs on A. parasiticus
compared to the untreated samples. Significance was set at
p< 0.05.
RESULTS
Aflatoxin B1 Exposures Do Not Inhibit
V. gazogenes Growth
As a first step in understanding how V. gazogenes, responds to
aflatoxin B1, we investigated the effect of three different doses
of aflatoxin B1 on the growth of V. gazogenes. The doses, 10, 30,
and 50 ppb were either below, approximately equal to or fivefold
higher than the highest-allowed aflatoxin level (20 ppb) in food
and feed (Mazumder and Sasmal, 2001; CAST, 2003; Liu and
Wu, 2010). Time-course absorbance readings were recorded to
compare the growth rates of V. gazogenes, in presence of aflatoxin
B1, with untreated-controls. As shown in Figure 1, none of the
aflatoxin B1 doses demonstrated any significant effect on the
growth of V. gazogenes.
Aflatoxin B1 Exposures Do Not Inhibit
Prodigiosin Synthesis
Next, we investigated the effect of aflatoxin B1 exposures on
the production of prodigiosins by V. gazogenes. The prodigiosin
fraction was obtained from cells (either untreated control cells
or cells exposed to aflatoxin B1) using our optimized laboratory
protocol (see Materials and Methods). Since, the prodigiosins
exhibit an absorbance peak at 530 nm (Figure 2A), this
wavelength was used to compare prodigiosin levels between
experimental treatments and controls at three different time-
points of growth (12, 18, and 42 h). Our results (Figure 2B)
demonstrated that although cells exposed to aflatoxin B1
showed a minor increase in absorbance values compared
to the untreated samples, the difference was not statistically
significant.
1http://www.ncbi.nlm.nih.gov/tools/primer-blast/
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FIGURE 1 | Effect of aflatoxin B1 exposure on Vibrio gazogenes
growth. Growth comparisons were performed using comparisons of 600 nm
absorbance values between untreated V. gazogenes cultures and cultures
were supplemented with 10, 30, and 50 ppb of aflatoxin B1. Statistical
significance of two-tailed p-values were determined using an unpaired t-test
with sample size of 3 and significance set as p < 0.05.
Additional V. gazogenes Metabolite
Fraction Obtained by Bacterial Exposure
to Aflatoxin B1: Aflatoxin Response
Metabolites (ARMs)
While growth and prodigiosin production by V. gazogenes
was not affected in presence of aflatoxin B1, we observed
that exposure to aflatoxin B1 resulted in a distinct alteration
of color in the growth medium (Figure 3A) suggesting the
presence of a different metabolite compared to untreated cells.
Based on the ‘blue-shift’ in color of the growth medium
(bright red to orange) upon addition of aflatoxin B1, we
hypothesized that the bacterium synthesizes an additional
metabolite fraction under these conditions with a corresponding
absorbance lower than that of the prodigiosin fraction. To
test this, we performed UV-Vis spectral analysis on the
metabolite fractions of aflatoxin B1-treated samples. The
Vibrio metabolite fractions obtained from aflatoxin B1 treated
samples demonstrated a new absorbance peak at 240 nm
(Figure 3B). This suggested that aflatoxin B1 exposure affects
the cellular metabolism of V. gazogenes resulting in a different
metabolite profile, compared to the untreated control. Here,
we denote this additional metabolite fraction in response
to aflatoxin B1 exposure as ‘aflatoxin response metabolites
(ARMs).’
ARMs Do Not Inhibit A. parasiticus
Growth but Inhibit Aflatoxin Synthesis
Next we proceeded to investigate whether ARMs affect
the aflatoxin synthesis in the model aflatoxin B1 producer,
A. parasticus. The activation of ARM production by Vibrio
occurred upon addition of aflatoxin B1 to their growth medium.
Therefore, we envisioned this alteration of metabolite profiles
as a defensive response from Vibrio cells. We hypothesized
that ARMs will have a specific inhibitory effect on aflatoxin
synthesis in the producer cells. To test this we studied the
growth and aflatoxin production by A. parasiticus in presence
FIGURE 2 | Effect of aflatoxin B1 exposure on prodigiosin production.
(A) UV-Vis spectral profile of a prodigiosin-rich metabolite fraction
demonstrating peak absorbance at 530 nm. (B) Comparison of absorbance
values at 530 nm, of methanol extracts from untreated V. gazogenes cultures
and cultures were supplemented with 10, 30, and 50 ppb of aflatoxin B1.
Statistical significance of two-tailed p-values were determined using an
unpaired t-test, with n = 3, and p < 0.05 as significance level.
of two different doses of the ARMs metabolite fraction (1
and 2 µg per mL of growth medium); the doses were chosen
arbitrarily. To compare the levels of aflatoxin biosynthesis in
A. parasiticus exposed to ARMs exposed with the untreated
cells, we adopted a semi-quantitative approach in which we
compared the intensities of aflatoxin 1 and aflatoxin B2
bands on the TLC plates (see Materials and Methods). As
predicted, our TLC results generated from 40 h cultures
of A. parasiticus, demonstrated that ARMs applied at the
concentration of 2 µg per mL of growth medium inhibited
both aflatoxin B1 and aflatoxin B2 by approximately twofold
(Figure 4A). Since, the drop in aflatoxin synthesis could also
have resulted from the inhibition of A. parasiticus growth,
we next compared the dry-weights of the A. parasiticus
mycelia exposed to 1 and 2 µg per mL of ARMs extract
with the untreated control mycelia. As shown in Figure 4B,
addition of ARMs to the growth medium did not result any
significant change in A. parasiticus dry weight, suggesting
that inhibition of aflatoxin synthesis in A. parasiticus by
ARMs was a direct effect and not a growth dependent
effect.
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FIGURE 3 | Aflatoxin-response metabolites (ARMs) produced by the
bacterium V. gazogenes during exposure to aflatoxin B1 (AFB1).
(A) Representative flasks demonstrating the differences in appearance of
untreated V. gazogenes cultures and the aflatoxin B1 supplemented cultures.
(B) Comparison of UV-Vis profiles of the methanol extracts from untreated and
supplemented V. gazogenes cultures.
ARMs Metabolite Fraction Displays a
Different HPLC Trace Compared to
Prodigiosin Fraction
Our UV-Vis spectral analysis suggested that ARMs were
synthesized by V. gazogenes upon exposure to aflatoxin. We
then proceeded to confirm that this fraction (peak absorbance
at 240 nm) was composed of metabolites of molecular masses
that are different from the Vibrio’s prodigiosin fraction (peak
absorbance at 530 nm). As shown in Figure 5, HPLC
traces showed that the prodigiosin fraction predominantly
demonstrated the expected molecular weight of 324 D,
corresponding to the known prodigiosin. The HPLC trace of
ARMs on the contrary was clearly different, with a predominantly
displayed molecular mass 232 D, which demonstrate that the
metabolite fraction of ARMs was chemically different from
the Vibrio’s prodigiosin fraction. These results suggest that the
differential metabolite profile in response to aflatoxin exposure
can occur either due to synthesis of new metabolites by
V. gazogenes or due to breakdown of prodigiosins resulting
in novel smaller molecules with aflatoxin synthesis inhibitory
activity.
ARMs Inhibit A. parasiticus Aflatoxin
Biosynthesis at the Level of Transcript
Accumulation
The fungal growth and aflatoxin results then prompted us
to investigate whether aflatoxin biosynthesis was inhibited at
the level of transcript accumulation of aflatoxin genes. To
conduct this analysis we performed a quantitative comparison of
transcript accumulation of two genes nor-1, and ver-1 that encode
two enzymes, Nor-1, Vbs, and Ver-1, respectively, involved in the
aflatoxin biosynthetic pathway (Chanda et al., 2009). Activation
of these genes in A. parasiticus occurs at 24 h, and transcripts
of all aflatoxin enzymes accumulate by 30 h, when the fungus is
grown in YES growth medium (Roze et al., 2007a). Hence, we
chose to examine the effects of ARMs extract on A. parasiticus
at three different time-points, 24, 30 and 40 h, a time-point
when aflatoxin is synthesized by the fungus at peak levels (Roze
et al., 2007a). In addition to these genes, we also compared the
transcript accumulation of the aflatoxin pathway regulator, aflR,
at the same time points. As shown in Figure 6, nor-1, ver-1 as well
FIGURE 4 | Effect of ARMs on aflatoxin biosynthesis and fungal growth. (A) Effect on aflatoxin accumulation in the growth media. Left panel, a representative
TLC plate providing a qualitative comparison of aflatoxin accumulation in the untreated culture and cultures that were supplemented with 1 and 2 µg/mL ARMs
extract and the vehicle (DMSO). Right panel, semi-quantitative comparative comparisons of band intensities of aflatoxin B1 and aflatoxin B2. a, significant difference
in band intensity compared to the vehicle control. (B) Effect on growth. Comparison of dry-weight measurements. Bars represent measurements relative to the
dry-weight of untreated cells. Statistical significance of two-tailed p-values were determined using an unpaired t-test, with sample size of n = 3 and p < 0.05 set as
level of significance.
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FIGURE 5 | Comparison of HPLC traces of ARMs extract and the prodigiosin fraction of V. gazogenes.
FIGURE 6 | Effects of ARMs on Aspergillus parasiticus gene expression. (A) Comparison of transcript accumulation of aflatoxin-synthesis regulatory genes in
A. parasiticus. mRNA levels for each gene were observed at 24 h (aflatoxin synthesis start point), 30 and 40 h time points (aflatoxin synthesis is activated and
reaches peak levels by 40 h). Black bars, cells grown in presence of ARMs (2 µg/mL), Gray Bars, DMSO (vehicle) control. (B) Comparison of transcript accumulation
of two global regulators of secondary metabolism, veA and laeA at the same time-points. Statistical significance of difference in transcript accumulation between
control and ARMs-treated cells were determined using an unpaired t-test with sample size of 3 and two tailed p < 0.05 set as level of significance. a, p < 0.05.
as the aflR genes transcript levels demonstrated≥5 fold reduction
in presence of ARMs extract compared to the vehicle control
by 30 h. Hence, our results suggest that ARMs extract reduces
aflatoxin synthesis at the level of transcript accumulation.
ARMs Inhibit Transcript Accumulation of
the Secondary Metabolism Global
Regulator, laeA but not veA
Since the regulatory network of the aflatoxin biosynthesis
pathway is integral to the global network of secondary
metabolism in A. parasiticus (Chanda et al., 2009), we also
proceeded to investigate whether, ARMs target the global
regulation of secondary metabolism. One key global regulatory
complex of fungal secondary metabolism is the Velvet complex
which consists of proteins VeA, LaeA and other regulators
(Bayram et al., 2008). Central to this complex is the cross-
talk between the two global regulatory proteins, LaeA, a
methyltransferase that is key to the epigenetic regulation of
aflatoxin biosynthetic pathway (Bok and Keller, 2004), and
VeA, a light responsive regulatory protein that migrates from
cytoplasm to the nucleus in absence of light to particpate
in the VeA complex (Bayram et al., 2008). In this study we
investigated whether ARMs affect transcript accumulation of
either laeA or veA genes. To our surprise we found that, while
no significant changes occurred in veA transcripts, the laeA
transcript accumulation was reduced by ∼2 fold by 30 h and ∼4
fold by 40 h (Figure 7), suggesting that ARMs inhibit aflatoxin
biosynthesis at least in part, through inhibition of laeA gene
activation.
DISCUSSION
Here, we demonstrate the feasibility of a novel system for
generation of aflatoxin biosynthesis inhibitors, a concept that is
analogous to the generation of antibodies upon antigen exposure.
Our data reveal that the estuarine bacterium V. gazogenes,
upon aflatoxin exposure, produces a metabolite profile that
is chemically different from untreated-cells. Upon isolation of
the ARMs and applying them on the aflatoxin producer cells,
we found that the metabolites inhibit aflatoxin biosynthesis at
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FIGURE 7 | Schematic representation of the inhibitory effect of ARMs on aflatoxin biosynthesis. Current study demonstrates that ARMs inhibit aflatoxin
biosynthesis in A. parasiticus at the level of gene expression. We hypothesize that the inhibition of aflatoxin genes as exemplified by the decreased nor-1, ver-1, and
aflR transcripts in presence of ARMs can be the effect of one or both of the following: (1) inhibition of laeA expression, which in turn can have inhibitory impact on the
activation of the aflatoxin genes, or (2) a dual inhibition caused by direct inhibition on aflatoxin gene cluster activation along with a laeA mediated inhibition. Red
dotted arrows, regulatory roles established in previous studies, red solid lines, inhibitory effect, gray curved arrows, gene activation, gray solid line, schematic of the
aflatoxin gene cluster showing relative positions of nor-1, ver-1, and aflR in the cluster, brown solid line, laeA gene.
the level of transcript accumulation of aflatoxin biosynthesis
regulatory genes. Based on our current study we propose two
possible explanations underlying this inhibition (illustrated in the
schematic in Figure 7). One possible mechanism of inhibition
is through the regulation of the laeA gene activation. The
laeA transcripts dropped by 2–4 fold during 30–40 h time
points suggesting that ARMs inhibit the formation of the
Velvet complex, a protein complex comprising LaeA protein
that regulate fungal secondary metabolism (Bayram et al.,
2008). Alternatively, it is also possible that in addition to laeA
mediated inhibition ARMs inhibit the activation of aflatoxin
genes directly. Fungal growth was not inhibited during the
ARMs-mediated inhibition of aflatoxin biosynthesis, suggesting
that the metabolites target secondary metabolism specifically.
Future studies will identify the molecule(s) within ARMs that
results in the aflatoxin inhibition. From our current preliminary
studies, we postulate that two or more compounds generated
in response to aflatoxin exposure act either complementarily
or synergistically to inhibit aflatoxin synthesis inhibition. These
collaborative effects will be determined in those functional
characterization studies with the purified compounds.
It is important to emphasize that specific aflatoxin inhibitory
natural products that have been characterized to-date were
reported primarily from terrestrial organisms whose ecological
domains likely overlap with those of the aflatoxin producers.
Examples include natural products and volatiles from plants
(Cleveland et al., 2009; Roze et al., 2011; Chitarrini et al., 2014),
fungi (Ono et al., 1997; Yoshinari et al., 2010; Hua et al., 2014)
and bacteria (Jermnak et al., 2013; Wang et al., 2013; Kong
et al., 2014). Our study provides the first evidence, to the best
of our knowledge, of an organism that demonstrates the ability
of synthesizing aflatoxin inhibitors, while not sharing ecological
niches with aflatoxin producers at all. Also this is the first report,
to the best of our knowledge, of a Vibrio-producing metabolite(s)
that specifically inhibit aflatoxin biosynthesis without affecting
fungal growth. It is possible that mycotoxin triggered synthesis
of mycotoxin inhibitors is a phenomenon that is conserved in the
Vibrio species. Alternatively, it is also possible that V. gazogenes is
a chemically gifted organism that has genetically evolved with the
rising mycotoxin levels in the environment with global changes
in climate (Kolpin et al., 2014; Rangel et al., 2015).
The effect of ARMs mediated down-regulation of laeA gene,
but not veA gene suggests that the metabolites target cellular
signaling receptors that specifically regulate laeA gene expression.
Since LaeA is a global regulator of secondary metabolism and
influences several mycotoxin biosynthetic pathways (Keller et al.,
2005), we anticipate that aflatoxin inhibitor within ARMs will
inhibit other mycotoxins as well. Hence, for our follow-up
studies we will categorize these as secondary metabolism specific
inhibitors instead denoting these as specific inhibitors against
aflatoxin biosynthesis.
Current investigations in our laboratory reveal that other
fungal secondary metabolites trigger synthesis of metabolite
fractions in V. gazogenes that demonstrate different HPLC traces
compared to either prodigiosins or ARMs fractions. These results
implicate the need to examine the regulation of Vibrio genes
under different environmental signals. It appears from our
studies that many areas of the Vibrio genome remain silent under
standard laboratory growth conditions and can be activated as
needed to generate metabolites that are relevant to the public
health. Our future studies will shed light on these silent areas
of the V. gazogenes genome that encode the biosynthesis of the
secondary metabolism modulatory metabolites; the knowledge
will enable us to clone these areas on plasmids and engineer them
as needed with the goal of purifying these compounds in large
quantities.
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